Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II)

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent disorder, seen in 20–30% of young adult prisoners. Pharmacoepidemiological studies, a small randomised controlled trial and open trial data of methylphenidate suggest clinically significant reductions in ADHD symptoms,...

Descripción completa

Detalles Bibliográficos
Autores principales: Asherson, Philip, Johansson, Lena, Holland, Rachel, Fahy, Tom, Forester, Andrew, Howitt, Sheila, Lawrie, Stephen, Strang, John, Young, Susan, Landau, Sabine, Thomson, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889577/
https://www.ncbi.nlm.nih.gov/pubmed/31791384
http://dx.doi.org/10.1186/s13063-019-3705-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889577/
https://www.ncbi.nlm.nih.gov/pubmed/31791384
http://dx.doi.org/10.1186/s13063-019-3705-9

Ejemplares similares